Deadly new Covid variant sweeps across Europe—are we heading for another lockdown?

Pallavi Madhiraju- September 17, 2024 0

A fresh wave of Covid-19 concern has swept across Europe as a new variant, known as XEC, gains ground, showing signs of becoming the dominant ... Read More

COVID strikes back: Is the world prepared for the EG.5 onslaught?

Pallavi Madhiraju- August 6, 2023 0

Just when the world was breathing a sigh of relief, COVID-19's new and aggressive EG.5 variant is making headlines. The recent surge, particularly gripping the ... Read More

Gennova’s GEMCOVAC-OM Omicron-specific mRNA-based booster vaccine gets EUA in India

Pallavi Madhiraju- June 21, 2023 0

The Department of Biotechnology (DBT), part of the Indian Ministry of Science & Technology, has revealed that the Omicron-specific mRNA-based booster vaccine, developed by Pune-based ... Read More

Everest Medicines commissions mRNA vaccine production plant in Jiashan

Raghuram Kadari- January 2, 2023 0

Everest Medicines, a China-based biopharmaceutical company, has commenced operations at its mRNA vaccine production plant in Jiashan, Zhejiang Province, thereby becoming a fully-integrated biopharma. With ... Read More

FDA grants EUA for Omicron-adapted Covid-19 vaccine for children below five

Raghuram Kadari- December 9, 2022 0

Pfizer and BioNTech have received the US Food and Drug Administration (FDA) emergency use authorization (EUA) for their Omicron BA.4/BA.5-adapted bivalent Covid-19 vaccine for children ... Read More

Lilly gets FDA EUA for bebtelovimab in mild-to-moderate Covid-19

pallavi123- February 12, 2022 0

Eli Lilly and Company (Lilly) has secured Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for bebtelovimab for the treatment of ... Read More

Celltrion files IND for phase 3 trial of inhaled Covid-19 cocktail therapy

pallavi123- February 7, 2022 0

Celltrion Group (Celltrion Healthcare), a South Korean pharma company, has submitted an investigational new drug (IND) application to carry out a global phase 3 clinical ... Read More

Regeneron says REGEN-COV monoclonal antibodies active against Omicron, Delta and other variants

pallavi123- December 19, 2021 0

Regeneron Pharmaceuticals said that the monoclonal antibodies of its REGEN-COV cocktail are active against all known variants of concern of Covid-19, including Omicron and Delta. ... Read More